logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
E

Enrique Espinosa

medicine department

41H指数
520论文数
6.7K被引数
收录论文 91
发表时间
logo
Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial恩考拉非尼联合比美替尼在BRAF突变黑色素瘤脑转移患者中的疗效：BECARE（GEM-2002）试验结果
errNeuro-Oncology Advances
IF4.1
err2026-09-21
err0
errOAAI
errPablo Cerezuela-Fuentes; Miguel-Angel Berciano-Guerrero; Eva Muñoz-Couselo; Pedro Sanchez Mauriño; Regina García Galindo; Lourdes Gutiérrez Sanz; José Balsalobre Yago; Teresa Puértolas; Carlos Aguado; Silvia Sequero; Guillermo Crespo; Cristina Aguayo; Enrique Espinosa; Pedro López; Rafael López Castro; Joaquín Fra Rodríguez; Gretel Benítez; Alberto Jacobo Cunquero-Tomás; Alfonso Berrocal; Ainara Soria
err分享
err收藏
Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy晚期黑色素瘤的免疫分类识别对PD1疗法无应答者
errcancer immunology, immunotherapy
IF0
err2026-04-28
err0
errOAAI
errAngelo Gámez-Pozo; Lucía Trilla-Fuertes; Fernando Becerril-Gómez; Pedro Lalanda-Delgado; Virtudes Soriano; Fernando Garicano Goldaraz; M. José Lecumberri; María Rodríguez de la Borbolla; Margarita Majem; Elisabeth Pérez-Ruiz; María González-Cao; Juana Oramas; Rocío López-Vacas; Alejandra Magdaleno; Joaquín Fra; Alfonso Martín-Carnicero; Mónica Corral; Teresa Puértolas; Ricardo Ramos-Ruiz; Enrique Espinosa; Juan Ángel Fresno Vara
err分享
err收藏
Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model二甲双胍增强化疗联合免疫疗法在TNBC（三阴性乳腺癌）体内模型中的疗效
errBIOMEDICINE & PHARMACOTHERAPY
IF7.5
err2026-03-18
err0
errOAAI
errAngelo Gámez-Pozo; Luz Vega-Clemente; Lucía Trilla-Fuertes; Elena López-Camacho; Fernando Becerril-Gómez; David Alonso-Martín; Rocío López-Vacas; Pedro Lalanda-Delgado; Pilar Zamora; Mariano García-Arranz; Juan Ángel Fresno Vara; Enrique Espinosa
err分享
err收藏
Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801标题：西班牙免疫治疗和靶向治疗时代未知原发灶黑色素瘤的特征：前瞻性真实世界研究GEM 1801的结果
errClinical and Translational Oncology
IF2.5
err2025-12-20
err0
PREAI
errPablo Cerezuela-Fuentes; Antonio Piñero-Madrona; Eva Muñoz-Couselo; José Luis Manzano; Miguel-Ángel Berciano-Guerrero; Margarita Majem; Enrique Espinosa; Ainara Soria; Pablo Ayala de Miguel; Almudena García Castaño; Guillermo Crespo; Lourdes Gutiérrez Sanz; Carlos Aguado de la Rosa; Luis Antonio Fernández-Morales; Teresa Puértolas; Joaquín Fra Rodríguez; María Rodríguez de la Borbolla; Lorena Bellido; Rafael López Castro; Victor Navarro Pérez; Francisco Ramón García Arroyo; José Carlos Villa Guzmán; Begoña Campos Balea; Berta Hernández; Salvador Martín Algarra; Iván Márquez-Rodas
err分享
err收藏
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study西班牙晚期黏膜黑色素瘤患者的治疗效果：来自真实世界GEM1801研究的结果
errMelanoma Research
IF0
err2025-12-01
err0
PREAI
errCerezuela-Fuentes, Pablo; Aguado de la Rosa, Carlos; Crespo, Guillermo; Berciano-Guerrero, Miguel-Angel; Soria, Ainara; Munoz-Couselo, Eva; Lopez Castro, Rafael; Majem, Margarita; Ayala de Miguel, Pablo; Manzano, Jose Luis; Bellido, Lorena; Lecumberri, Ma Jose; Corral Subias, Monica; Villa Guzman, Jose Carlos; Hernandez, Berta; Espinosa, Enrique; Puertolas, Teresa; Gutierrez Sanz, Lourdes; Medina Martinez, Javier; Palomar Abril, Vicente; Martin Algarra, Salvador; Marquez-Rodas, Ivan
err分享
err收藏
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801应答率和长期生存率在晚期黑色素瘤患者中的表现：来自前瞻性队列研究gem-1801的数据
errClinical and Translational Oncology
IF2.5
err2025-11-28
err0
errOAAI
errEnrique Espinosa; Miguel-Ángel Berciano-Guerrero; Eva Muñoz-Couselo; Teresa Puértolas; José Luis Manzano; Ainara Soria; Pablo Ayala de Miguel; Guillermo Crespo; Lourdes Gutiérrez Sanz; Pablo Cerezuela-Fuentes; Carlos Aguado de la Rosa; Margarita Majem; Almudena García Castaño; Alfonso Berrocal; Francisco Ramon García Arroyo; María Rodríguez de la Borbolla; Lorena Bellido; Javier Medina Martínez; Luis Antonio Fernández; Alfonso Martin Carnicero; Rafael López Castro; Aida Bujosa Rodríguez; Mª José Lecumberri; José Carlos Villa Guzmán; Begoña Campos Balea; Joaquín Fra Rodríguez; Javier Valdivia Bautista; Victor Navarro Pérez; Karmele Mujika; Mónica Corral Subias; Berta Hernández; Salvador Martín Algarra; Iván Márquez-Rodas
err分享
err收藏
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry肢端黑色素瘤患者中基于抗PD-1抗体免疫疗法的效果不佳：西班牙黑色素瘤组（GEM）登记研究的结果
errclinical translational oncology
IF0
err2025-08-21
err0
PREAI
errMaria Gonzalez-Cao; Miguel-Ángel Berciano-Guerrero; Eva Muñoz-Couselo; José Luis Manzano; Pablo Cerezuela-Fuentes; Guillermo Crespo; Ainara Soria; Pablo Ayala de Miguel; Lourdes Gutiérrez Sanz; Carlos Aguado de la Rosa; Almudena García Castaño; Teresa Puértolas; Enrique Espinosa; Javier Medina; Lorena Bellido; Alfonso Berrocal; Margarita Majem; Rafael López Castro; Luis Antonio Fernandez; Francisco Garcia; Maria Rodriguez de la Borbolla; Salvador Martín Algarra; Iván Márquez-Rodas
err分享
err收藏
Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-02-26
err0
errOAAI
errSoria, Ainara; Maurino, Pedro Sanchez; Domingo, Juan Jose Serrano; Galindo, Regina Garcia; Sequero, Silvia; Sanz, Lourdes Gutierrez; Crespo, Guillermo; Diaz-Beveridge, Roberto; Puertolas, Teresa; Lopez, Pedro; Rodriguez, Joaquin Fra; Castro, Rafael Lopez; Aguayo, Cristina; Valdivia, Javier; Cunquero-Tomas, Alberto Jacobo; Benitez, Gretel; de Miguel, Pablo Ayala; Espinosa, Enrique; Munoz-Couselo, Eva; Campos, Begona; Sanchez, Lourdes Garcia; Cerezuela-Fuentes, Pablo
err分享
err收藏
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
errAMERICAN JOURNAL OF CLINICAL DERMATOLOGY
IF8.8
err2024-10-08
err0
errOAAI
errMortier, Laurent; Villabona, Lisa; Lawrence, Ben; Arance, Ana; Butler, Marcus O.; Beylot-Barry, Marie; Saiag, Philippe; Samimi, Mahtab; Ascierto, Paolo A.; Spada, Francesca; De Pontville, Michel; Maio, Michele; Berrocal, Alfonso; Espinosa, Enrique; Capdevila, Jaume; Levin, Max; Das, Debasmita; Krepler, Clemens; Grebennik, Dmitri; Chiarion-Sileni, Vanna
err分享
err收藏
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs抗癌药物分类: FDA和EMA批准药物的更新
errCANCER AND METASTASIS REVIEWS
IF8.7
err2024-07-05
err1
errOAAI
errOstios-Garcia, Lorena; Perez, Daniel Martinez; Castelo, Beatriz; Herradon, Noelia Hernandez; Zamora, Pilar; Feliu, Jaime; Espinosa, Enrique
err分享
err收藏
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
errNATURE COMMUNICATIONS
IF15.7
err2024-06-24
err2
errOAAI
errLorenzo-Sanz, Laura; Lopez-Cerda, Marta; da Silva-Diz, Victoria; Artes, Marta H.; Llop, Sandra; Penin, Rosa M.; Bermejo, Josep Oriol; Gonzalez-Suarez, Eva; Esteller, Manel; Vinals, Francesc; Espinosa, Enrique; Oliva, Marc; Piulats, Josep M.; Martin-Liberal, Juan; Munoz, Purificacion
err分享
err收藏
Randomized Phase II trial evaluating three antidiarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errGil-Gil, Miguel; Martin, Miguel; Carrasco, Eva; Galve, Elena; Martinez-Janez, Noelia; Gonzalez-Santiago, Santiago; Adamo, Barbara; Valero, Maria; Martinez, Clara; Guerrero, Angel; Novoa, Silvia Antolin; Ruiz-Borrego, Manuel; Blancas, Isabel; Andres, Raquel; Alonso-Romero, Jose L.; Andrea, Vethencourt; Chacon, J. Ignacio; Chavarria, Natalia; Espinosa, Enrique; Hernando, Blanca; Adrover, Encarnacion; Rojo, Federico; Casas, Maribel; McCulloch, Leanne; Vedovato, Jean-Claude
err分享
err收藏
Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errZamora, Pilar; Pozo, Angelo Gamez; Vega-Clemente, Luz; Lopez-Camacho, Elena; Trilla-Fuertes, Lucia; Alonso-Martin, David; Vara, Juan Angel Fresno; Garcia-Arranz, Mariano; Espinosa, Enrique
err分享
err收藏
Prediction of recurrence in triple negative breast cancer patients after receiving neoadjuvanttreatment using plasma metabolomics
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errSanchez-Rovira, Pedro; Urbano-Cubero, Rocio; Pozo, Angelo Gamez; Gonzalez-Olmedo, Carmen; Cano-Jimenez, Alicia; Zapater-Moros, Andrea; Diaz-Beltran, Leticia; Trilla-Fuertes, Lucia; Diaz-Almiron, Mariana; Espinosa, Enrique; Zamora, Pilar; Vara, Juan Angel Fresno
err分享
err收藏
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis一线转移性葡萄膜黑色素瘤中tebentafusp与nivolumab联合ipilimumab的总生存率: 倾向评分加权分析
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err6
errOAAI
errPiulats, J. M.; Watkins, C.; Costa-Garcia, M.; del Carpio, L.; Piperno-Neumann, S.; Rutkowski, P.; Hassel, J. C.; Espinosa, E.; de la Cruz-Merino, L.; Ochsenreither, S.; Shoushtari, A. N.; Orloff, M.; Salama, A. K. S.; Goodall, H. M.; Baurain, J. -F.; Nathan, P.
err分享
err收藏
Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
PREAI
errCerezuela-Fuentes, P.; Pinero-Madrona, A.; Munoz-Couselo, E.; Manzano, J. L.; Berciano-Guerrero, M-A.; Majem, M.; Espinosa, E.; Soria, A.; Ayala de Miguel, P.; Garcia Castano, A.; Crespo, G.; Gutierrez Sanz, L.; Aguado de la Rosa, C.; Fernandez-Morales, L. A.; Puertolas, T.; Fra, J.; Rodriguez de la Borbolla, M.; Bellido, L.; Martin Algarra, S.; Marquez-Rodas, I.
err分享
err收藏
Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err1
PREAI
errWeichenthal, M.; Schadendorf, D.; Bastholt, L.; Gavrilova, I.; Haanen, J. B. A. G.; Mangana, J.; Espinosa, E.; Svane, I. M.; Wouters, M.; Ellebaek, E.; Mohr, P.; Marques Rodas, I.; Asher, N.; Dummer, R.; Gaudy Marqueste, C.; Aya, F.; Gogas, H.; Lebbe, C.; Rutkowski, P.; Ascierto, P. A.
err分享
err收藏
Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE)
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err0
errOAAI
errSoria, A.; Sanchez Maurino, P.; Garcia Galindo, R.; Sequero, S.; Gutierrez Sanz, L.; Crespo, G.; Diaz-Beveridge, R.; Puertolas, T.; Lopez, P.; Fra Rodriguez, J.; Lopez Castro, R.; Aguayo, C.; Valdivia, J.; Cunquero-Tomas, A.; Benitez, G.; Ayala de Miguel, P.; Espinosa, E.; Munoz-Couselo, E.; Campos, B.; Cerezuela-Fuentes, P.
err分享
err收藏
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients
errMETABOLOMICS
IF3.3
err2023-06-21
err4
PREAI
errZapater-Moros, Andrea; Diaz-Beltran, Leticia; Gamez-Pozo, Angelo; Trilla-Fuertes, Lucia; Lumbreras-Herrera, Maria Isabel; Lopez-Camacho, Elena; Gonzalez-Olmedo, Carmen; Espinosa, Enrique; Zamora, Pilar; Sanchez-Rovira, Pedro; Fresno Vara, Juan Angel
err分享
err收藏
Proteomics Characterization of Clear Cell Renal Cell Carcinoma肾透明细胞癌的蛋白质组学研究
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2023-01-03
err2
errOAAI
errMiranda-Poma, Jesus; Trilla-Fuertes, Lucia; Lopez-Vacas, Rocio; Lopez-Camacho, Elena; Garcia-Fernandez, Eugenia; Pertejo, Ana; Lumbreras-Herrera, Maria, I; Zapater-Moros, Andrea; Diaz-Almiron, Mariana; Dittmann, Antje; Fresno Vara, Juan Angel; Espinosa, Enrique; Gonzalez-Peramato, Pilar; Pinto-Marin, Alvaro; Gamez-Pozo, Angelo
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Dirk Schadendorf
H 指数: 182 · 论文数: 2.4K
M
Manel Esteller
H 指数: 165 · 论文数: 1.6K
C
Caroline Robert
H 指数: 154 · 论文数: 1.5K
R
Reinhard Dummer
H 指数: 152 · 论文数: 2.8K
C
Claus Garbe
H 指数: 130 · 论文数: 1.5K
查看更多